Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lipid bilayer of retinal cell membranes, particularly in photoreceptor outer segments and the retinal pigment epithelium (RPE), serves as the essential structural and functional matrix for the visual cycle. These membranes are uniquely characterized by a high concentration of long-chain polyunsaturated fatty acids, such as docosahexaenoic acid (DHA), which facilitate the high fluidity necessary for rapid phototransduction signaling (Source: NIH, PubMed). In pathological conditions like Stargardt disease and dry age-related macular degeneration (AMD), the bilayer becomes the primary site for the accumulation of toxic fluorophores like A2E, a component of lipofuscin (Source: PubMed). This accumulation triggers oxidative stress, membrane permeabilization, and chronic inflammation, ultimately leading to the degeneration of retinal cells. Pharmacological interventions targeting this environment often aim to reduce the formation of these toxic lipid-bisretinoid aggregates or provide antioxidant protection to maintain membrane integrity (Source: Belite Bio, ClinicalTrials.gov). Consequently, the maintenance of this specialized lipid environment is a critical therapeutic strategy for preserving vision in progressive retinal dystrophies.
Modulation of the visual cycle to reduce the formation and accumulation of toxic bisretinoid aggregates (e.g., A2E) within the membrane, and stabilization of the lipid environment against oxidative damage.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid bilayer of retinal cell membranes.